FEMY (Femasys) Short Ratio


FEMY Femasys Inc FEMY
56 GF Score
Price $4.02
GF Value $12.12
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Femasys Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FEMY
56GF Score
Femasys Inc FEMY
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Femasys (FEMY) Overvalued in 2026?

Based on GuruFocus' analysis, Femasys stock appears to be undervalued. The current stock price of $4.02 is trading 66.8% below its estimated GF Value™ of $12.12. GuruFocus considers Femasys to be Possible Value Trap.

Key valuation signals for FEMY:

  • Short Ratio:
  • GF Value™: $12.12 vs. price of $4.02 (66.8% below fair value)
  • GF Score™: 56/100 with 7 warning signs

No single metric tells the full story. See the FEMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Femasys Business Description

Address 3950 Johns Creek Court, Suite 100, Suwanee, GA, USA, 30024
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
56GF Score

Get the complete analysis for FEMY

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.02
Price
$12.12
GF Value